Activation of NF-κB is involved in 6-hydroxydopamine - But not MPP +-induced dopaminergic neuronal cell death: Its potential role as a survival determinant

Biochemical and Biophysical Research Communications

Volumn 322, Issue 3, 2004, Pages 727-733

  Park, Seong H ^a   Choi, Won Seok ^a   Yoon, So Young ^a   Ahn, Young Soo ^b   Oh, Young J ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

6 Hydroxydopamine; MN9D cells; MPP +; NF B; PDTC

Indexed keywords

1 METHYL 4 PHENYL 4 PHENYLPYRIDINIUM; ACETYLCYSTEINE; ANTIOXIDANT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOPAMINE; PROTEIN P50; PYRIDINIUM DERIVATIVE; PYRROLIDINE DITHIOCARBAMATE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; 1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL NUCLEUS; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EXPOSURE; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECT; GLIA; KINETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; PROTEIN TRANSPORT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL LINE; CELL SURVIVAL; DOPAMINE; KINETICS; NEUROGLIA; NEURONS; NF-KAPPA B; OXIDOPAMINE; PROTEIN TRANSPORT; PYRROLIDINES; THIOCARBAMATES;

EID: 4444281111     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.193     Document Type: Article

References (34)

1. A. Hartmann, and E.C. Hirsch Parkinson's disease: the apoptosis hypothesis revisited Adv. Neurol. 86 2001 143 153
2. P. Jenner Oxidative mechanisms in nigral cell death in Parkinson’s disease Mov. Disod. 12 Suppl. 1998 24 34
3. M.J. Leonardo, and D. Baltimore NF-kappa B: a pleotrophic mediator of inducible and tissue-specific gene control Cell 58 1989 227 229
4. J. Kucharczak, M.J. Simmons, Y. Fan, and C. Gelinas To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis Oncogene 22 2003 8961 8982
5. R. Romieu-Mourez, E. Landesman-Bollag, D.C. Seldin, A.M. Traish, F. Mercurio, and G.E. Sonenshein Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer Cancer Res. 61 2001 3810 3818
6. T. Henkel, T. Machleidt, I. Alkalay, M. Krönke, Y. Ben-Neriah, and P.A. Baeuerle Rapid proteolysis of IκB-Iα is necessary for activation of transcription factor NF-κB Nature 365 1993 182 185
7. M.P. Mattson, and S. Camandola NF-kappaB in neuronal plasticity and neurodegenerative disorders J. Clin. Invest. 107 2001 247 254
8. L.A. O'Neill, and C. Kaltschmidt NF-kappa B: a crucial transcription factor for glial and neuronal cell function Trends Neurosci. 20 1997 252 258
9. H.K. Choi, L.A. Won, P.J. Kontur, D.N. Hammond, A.P. Fox, B.H. Wainer, P.C. Hoffmann, and A. Heller Immortalization of embryonic mesencephalic dopaminergic neurons by somatic fusion Brain Res. 552 1991 67 76
10. H.K. Choi, L. Won, J.D. Roback, B.H. Wainer, and A. Heller Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions Proc. Natl. Acad. Sci. USA 89 1992 8943 8947
11. J.E. Bottenstein, and G.H. Sato Growth of a rat neuroblastoma cell line in serum-free supplemented medium Proc. Natl. Acad. Sci. USA 76 1979 514 517
12. W.S. Choi, E.H. Lee, C.W. Chung, Y.K. Jung, B.K. Jin, S.U. Kim, T.H. Oh, T.C. Saido, and Y.J. Oh Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2 J. Neurochem. 77 2001 1531 1541
13. E. Schreiber, P. Matthias, M.M. Muller, and W. Schaffner Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells Nucleic Acids Res. 17 1989 6419
14. +, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line Neurobiol. Dis. 3 1995 157 167
15. +-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins Exp. Neurol. 159 1999 274 282
16. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK J. Neurosci. Res. 57 1999 86 94
17. + downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells: protective role of Bcl-2 Biochem. Biophys. Res. Commun. 286 2001 659 665
18. B.S. Han, H.S. Hong, W.S. Choi, G.J. Markelonis, T.H. Oh, and Y.J. Oh Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment J. Neurosci. 23 2003 5069 5078
19. W.S. Choi, D.S. Eom, B.S. Han, W.K. Kim, B.H. Han, E.J. Choi, T.H. Oh, G.J. Markelonis, J.W. Cho, and Y.J. Oh Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons J. Biol. Chem. 279 2004 20451 20460
20. D. Blum, S. Torch, M.F. Nissou, and J.M. Verna 6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells Biochem. Pharmacol. 62 2001 473 481
21. H. Panet, A. Barzilai, D. Daily, E. Melamed, and D. Offen Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells J. Neurochem. 77 2001 391 398
22. H.J. Lee, S.H. Kim, K.W. Kim, J.H. Um, H.W. Lee, B.S. Chung, and C.D. Kang Antiapoptotic role of NF-kappaB in the auto-oxidized dopamine-induced apoptosis of PC12 cells J. Neurochem. 76 2001 602 609
23. Y. Levites, M.B. Youdim, G.. Maor, and S. Mandel Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures Biochem. Pharmacol. 63 2002 21 29
24. B.S. Han, J.S. Noh, B.J. Gwag, and Y.J. Oh A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau Neurosci. Lett. 341 2003 99 102
25. S. Hunot, B. Brugg, D. Ricard, P.P. Michel, M.P. Muriel, M. Ruberg, B.A. Faucheux, Y. Agid, and E.C. Hirsch Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease Proc. Natl. Acad. Sci. USA 94 1997 7531 7536
26. D.S. Cassarino, E.M. Halvorsen, R.H. Swerdlow, N.N. Abramova, W.D. Parker Jr., T.W. Sturgill, and J.P. Bennett Jr. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of parkinson's disease J. Neurochem. 74 2000 1384 1392
27. T. Dehmer, M.T. Heneka, M. Sastre, J. Dichgans, and J.B. Schulz Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappaB induction and block of NF kappaB and iNOS activation J. Neurochem. 88 2004 494 501
28. G.A. de Erausquin, K. Hyrc, D.A. Dorsey, D. Mamah, M. Dokucu, D.H. Masco, T. Walton, K. Dikranian, M. Soriano, J.M. Garcia Verdugo, M.P. Goldberg, and L.L. Dugan Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons Mol. Pharmacol. 63 2003 784 790
29. W.J. Nicklas, I. Vyas, and R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridinium, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sci. 36 1985 2503 2508
30. J. Bilsland, S. Roy, S. Xanthoudakis, D.W. Nicholson, Y. Han, E. Grimm, F. Hefti, and S.J. Harper Caspase inhibitors attenuate 1-methyl-4- phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons J. Neurosci. 22 2002 2637 2649
31. V. Jackson-Lewis, M. Jakowec, R.E. Burke, and S. Przedborski Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurodegeneration 4 1995 257 269
32. J. Lotharius, L.L. Dugan, and K.L. O'Malley Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons J. Neurosci. 19 1999 1284 1293
33. + inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1) Exp. Cell Res. 250 1999 75 85
34. P. Teismann, M. Schwaninger, F. Weih, and B. Ferger Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease Neuroreport 12 2001 1049 1053